default author photo

Kai-Xin Du

Nanjing Medical University

SCHOLARLY PAPERS

1

DOWNLOADS

82

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Penpulimab in Combination with Lenalidomide and R-GemOx Regimen (R2-GemOx-PD1i) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Multicentre, Single-Arm, Phase 2 Trial

Number of pages: 27 Posted: 01 May 2025
Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University, Nanjing Medical University, Anhui Medical University, Nanjing Medical University, Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University, Nanjing Medical University, The First Affiliated Hospital of Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology, Nanjing Medical University - Department of Hematology and The First Affiliated Hospital of Nanjing Medical University - Department of Hematology
Downloads 82 (790,029)

Abstract:

Loading...

DLBCL, penpulimab, lenalidomide, R-GemOx, efficacy, relapsed, refractory